Director's Suggestion Box

Internal Resources: for faculty and staff

Please email pathwebteam@jhmi.edu with questions or comments about this page.

JH Webmail

myJH

PDS Mail

Intranet

BBK

Lab

PDS test

Test Directory

Project Links

Document Mgt: WAM2

Resident Rotation Schedule

ActivTracker

CAP accreditation

Carpool Matching Service

ChemWatch

Clinical Pathology Unknowns

Team CORUS

Department Phone Listings

Diversity

Information for Faculty*

Google Scholar

HERO

HPO

IRB

Lab Licenses/Certificates

Medical Campus Map

New Innovations

Path Photo

Ombuds

PathWays

Plone

QI Projects

Red Cross Blood Drive Schedule

Research Links

Residency Interview Evaluation Sheet*

Resident Profiles

Pathology Symposium

JH Shuttles Tracking

Tissue Microarray Core

Time Tracking

Web Policies & Tips

*Hopkins computers & VPN only

What's New?

Hopkins Scientists Discover a New Type of Immune Cell

May 30, 2019

A team of scientists in the Department of Pathology, led by Abdel Rahim A. Hamad, D.V.M., Ph.D., report, in the May 30th advance on-line edition of the journal Cell, the remarkable discovery of a new type of immune cell. Historically T and B cells have been thought of as distinct arms of the immune system, Dr. Hamad and colleagues have discovered a rare cell that they call the X cell, that has features of both T and B cells. They further show that the newly discovered X cell may play a role in the development of type 1 diabetes. Congratulations to Dr. Hamad and his team on this very exciting discovery!

Click here for the press release.
Click here for the article in Cell

New Blood Test for Cancer

May 30, 2019

DELFI
A team of scientists at Johns Hopkins, led by Victor Velculescu, M.D.,Ph.D., report a new approach to a blood test for cancer. Reported in the journal Nature, the test can be used to detect seven different types of cancer, including pancreatic cancer. The test, called "DELFI" (DNA evaluation of fragments for early interception) detects abnormal fragments of DNA in the blood that have been shed by cancer cells. This technique takes advantage of the fact that cancers "package" their DNA differently than normal cells, and this unique packaging leads to unique patterns of DNA fragmentation that can be detected in the blood. DELFI detected close to 75% of cancer patients, and, remarkably, when combined with another blood test, DELFI could detect 91% of cancers.

Click here for the press release.

Congratulations, Dr. Danielle Hutchings!

May 24, 2019

Congratulations to our resident Danielle Hutchings, M.D.! Danielle was awarded the Frank Coulson Jr. Award for Clinical Excellence from the Miller Coulson Academy of Clinical Excellence here at Hopkins. The Miller Coulson Academy of Clinical Excellence recognizes and promotes excellence in patient care at Johns Hopkins for the benefit of the individuals and communities that we serve. The academy recognizes clinically excellent academic physicians who have achieved a level of mastery in communication & interpersonal skills, professionalism & humanism, and negotiation of the healthcare system. Congratulations Danielle!